These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 38287522)
21. Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1. Liu S; Chen W; Hu H; Zhang T; Wu T; Li X; Li Y; Kong Q; Lu H; Lu Z Breast Cancer Res; 2021 Dec; 23(1):115. PubMed ID: 34922601 [TBL] [Abstract][Full Text] [Related]
22. PVT1 affects growth of glioma microvascular endothelial cells by negatively regulating miR-186. Ma Y; Wang P; Xue Y; Qu C; Zheng J; Liu X; Ma J; Liu Y Tumour Biol; 2017 Mar; 39(3):1010428317694326. PubMed ID: 28351322 [TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer. Yang Q; Yu Y; Sun Z; Pan Y Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467 [TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer. Chen J; Yu Y; Li H; Hu Q; Chen X; He Y; Xue C; Ren F; Ren Z; Li J; Liu L; Duan Z; Cui G; Sun R Mol Cancer; 2019 Mar; 18(1):33. PubMed ID: 30825877 [TBL] [Abstract][Full Text] [Related]
25. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis. Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-32 targeting PTEN enhances M2 macrophage polarization in the glioma microenvironment and further promotes the progression of glioma. Bao L; Li X Mol Cell Biochem; 2019 Oct; 460(1-2):67-79. PubMed ID: 31218569 [TBL] [Abstract][Full Text] [Related]
27. Knockdown of lncRNA PVT1 Inhibits Glioma Progression by Regulating miR-424 Expression. Han Y; Li X; He F; Yan J; Ma C; Zheng X; Zhang J; Zhang D; Meng C; Zhang Z; Ji X Oncol Res; 2019 Jun; 27(6):681-690. PubMed ID: 30832754 [TBL] [Abstract][Full Text] [Related]
28. lncRNA PVT1 promotes the angiogenesis of vascular endothelial cell by targeting miR‑26b to activate CTGF/ANGPT2. Zheng J; Hu L; Cheng J; Xu J; Zhong Z; Yang Y; Yuan Z Int J Mol Med; 2018 Jul; 42(1):489-496. PubMed ID: 29620147 [TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA PVT1 predicts poor prognosis and promotes the progression of colorectal cancer through the miR-24-3p/NRP1 axis in zebrafish xenografts. Yin H; Gu S; Li G; Yu H; Zhang X; Zuo Y Neoplasma; 2023 Aug; 70(4):500-513. PubMed ID: 37789776 [TBL] [Abstract][Full Text] [Related]
30. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer. Dong C; Yin F; Zhu D; Cai X; Chen C; Liu X J Cell Biochem; 2020 Nov; 121(11):4470-4483. PubMed ID: 32030795 [TBL] [Abstract][Full Text] [Related]
31. Long non‑coding RNA Unigene56159 promotes glioblastoma multiforme cell proliferation and invasion through negatively regulating microRNA‑194‑5p. Jiang G; Dong H; Dong Y; Yang X Mol Med Rep; 2020 Feb; 21(2):768-776. PubMed ID: 31789416 [TBL] [Abstract][Full Text] [Related]
32. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA. Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158 [TBL] [Abstract][Full Text] [Related]
33. The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis. Iden M; Fye S; Li K; Chowdhury T; Ramchandran R; Rader JS PLoS One; 2016; 11(5):e0156274. PubMed ID: 27232880 [TBL] [Abstract][Full Text] [Related]
34. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival. Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630 [TBL] [Abstract][Full Text] [Related]
35. LncRNA PVT1 influences breast cancer cells glycolysis through sponging miR-145-5p. Qu H; Li X; Chen F; Zhang M; Lu X; Gu Y; Lv M; Lu C Genes Genomics; 2023 May; 45(5):581-592. PubMed ID: 36941464 [TBL] [Abstract][Full Text] [Related]
36. Amplified LncRNA PVT1 promotes lung cancer proliferation and metastasis by facilitating VEGFC expression. Pan Y; Liu L; Cheng Y; Yu J; Feng Y Biochem Cell Biol; 2020 Dec; 98(6):676-682. PubMed ID: 33167678 [TBL] [Abstract][Full Text] [Related]
37. A miR-125b/CSF1-CX3CL1/tumor-associated macrophage recruitment axis controls testicular germ cell tumor growth. Batool A; Wang YQ; Hao XX; Chen SR; Liu YX Cell Death Dis; 2018 Sep; 9(10):962. PubMed ID: 30237497 [TBL] [Abstract][Full Text] [Related]
38. LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway. Fu C; Li D; Zhang X; Liu N; Chi G; Jin X Neurotherapeutics; 2018 Oct; 15(4):1139-1157. PubMed ID: 30120709 [TBL] [Abstract][Full Text] [Related]
39. LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer. Yang J; Li C; Mudd A; Gu X Biosci Biotechnol Biochem; 2017 Dec; 81(12):2301-2306. PubMed ID: 29050519 [TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA PVT1: Emerging biomarker in digestive system cancer. Zhou DD; Liu XF; Lu CW; Pant OP; Liu XD Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 29027279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]